Research Article

Evaluation of the EndoPAT as a Tool to Assess Endothelial Function

Table 3

Reactive hyperaemia index.

Population TherapyStudy periodmean ± SDmin–maxCV

Renal patients6N/AN/A# 1.7–5.550%
Diabetic patients8MetforminCont. 1.5–2.216%
Diabetic patients8MetforminDiscont. 1.1–2.425%
Diabetic patients8Metformin + SACont. *,**1.7–3.728%
Diabetic patients8Metformin + SADiscount. *,**1.7–4.941%
Healthy volunteers12N/AN/A 1.3–2.829%

SA: sulfonylurea; SD: standard deviation; CV: coefficient of variation.
Cont: continuation of therapy; discount: 2 weeks of therapy discontinuation.
#visit 1, 2, and 3 and averaged (see materials and methods).
* versus healthy volunteers.
** versus diabetic patients on metformin only.